The risk of all-cause mortality (47.6% vs. 34.9%, p < 0.001), cardiovascular related mortality (10.5% vs. 7.2%, p < 0.001) and malignant neoplasms related mortality (10.1% vs. 8.2%, p = 0.049) increased with hs-CRP level elevation (p < 0.05). Here, CRP is linked to cancer.